These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1975094)

  • 1. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
    de Verneuil H; Metzger D
    Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
    Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
    Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.
    Baniahmad A; Köhne AC; Renkawitz R
    EMBO J; 1992 Mar; 11(3):1015-23. PubMed ID: 1347744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.
    Barettino D; Bugge TH; Bartunek P; Vivanco Ruiz MD; Sonntag-Buck V; Beug H; Zenke M; Stunnenberg HG
    EMBO J; 1993 Apr; 12(4):1343-54. PubMed ID: 8096810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
    Harbers M; Wahlström GM; Vennström B
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM; Harbers M; Vennström B
    Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.
    Chen HW; Privalsky ML
    Mol Cell Biol; 1993 Oct; 13(10):5970-80. PubMed ID: 8105369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
    Sharif M; Privalsky ML
    Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a cDNA encoding human Rev-ErbA alpha: transcription from the noncoding DNA strand of a thyroid hormone receptor gene results in a related protein that does not bind thyroid hormone.
    Lazar MA; Jones KE; Chin WW
    DNA Cell Biol; 1990 Mar; 9(2):77-83. PubMed ID: 1971514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.
    Desbois C; Aubert D; Legrand C; Pain B; Samarut J
    Cell; 1991 Nov; 67(4):731-40. PubMed ID: 1682056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The viral erbA oncogene protein, a constitutive repressor in animal cells, is a hormone-regulated activator in yeast.
    Privalsky ML; Sharif M; Yamamoto KR
    Cell; 1990 Dec; 63(6):1277-86. PubMed ID: 1979758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
    Glineur C; Zenke M; Beug H; Ghysdael J
    Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants.
    Damm K; Heyman RA; Umesono K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2989-93. PubMed ID: 8096643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.